Drug Search Results
Using advanced filters...
Advanced Search [+]

Lynestrenol

Alternative Names: lynestrenol
Clinical Status: Inactive
Latest Update: 2024-04-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: PR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Algeria | Austria | Bangladesh | Belgium | Brazil | Bulgaria | Chile | Colombia | Czech | Dominican Republic | Egypt | Finland | Germany | India | Indonesia | Ireland | Jordan | Lebanon | Luxembourg | Netherlands | New Zealand | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Serbia | Singapore | Slovenia | Spain | Sweden | Taiwan | Turkey | Ukraine | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Medical University of Vienna
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 4: Gender Dysphoria

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

Effects of sex hormones on the serotonin system

P4

Completed

Gender Dysphoria

2022-05-31

2025-06-06

Treatments

AP13214ONB

P4

Completed

Gender Dysphoria

2014-01-01

2019-03-19

Treatments